|
|
Volumn 105, Issue 12, 2002, Pages
|
|
Risks in risk stratification: what is relevant in practice?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CLINICAL TRIAL;
DEFIBRILLATOR;
ECONOMICS;
HEART ARRHYTHMIA;
HUMAN;
LETTER;
METHODOLOGY;
PATHOPHYSIOLOGY;
PREDICTION AND FORECASTING;
RISK ASSESSMENT;
STANDARD;
SUDDEN DEATH;
ADRENERGIC BETA-ANTAGONISTS;
ARRHYTHMIA;
CLINICAL TRIALS;
DEATH, SUDDEN, CARDIAC;
DEFIBRILLATORS, IMPLANTABLE;
HUMANS;
PREDICTIVE VALUE OF TESTS;
RESEARCH DESIGN;
RISK ASSESSMENT;
|
|
EID: 1842846196
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/hc1202.106048 Document Type: Letter |
|
Times cited : (2)
|
|
References (0)
|
